1-(4-FLUOROPHENYL)CYCLOHEXANECARBOXYLIC ACID, 95.0%, 5g

4-Methyl-1H-imidazol-2(3H)-one, 95.0%, 250mg

(4-Chloropyrimidin-5-yl)methanol, 98%, 100mg

(S)-2-((tert-Butoxycarbonyl)(methyl)amino)-4-fluoro-4-methylpentanoic acid, 98%, 250mg

2-(4-methylpiperazinomethyl)-2'-thiomethylbenzophenone, 97.0%, 1g

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 100mg

1-(3,4-Diaminophenyl)ethanone, 95.0%, 100mg

3-Methyl-4-morpholinoaniline, 95.0%, 100mg

Monohidrato de oxalato dipotásico, mínimo 98,5 %, pa, ACS, 250 g, envase de plástico.

2-Chloro-N-(pyrimidin-2-yl)propanamide hydrochloride, 95%, 5g

2-Bromo-1-(pyridin-2-yl)ethanone, 95.0%, 250mg

Phenyl morpholine-4-carboxylate, 95%, 5g

2-CYCLOPROPYLCYCLOBUTANOL, 95.0%, 1g